Dermata DRMA Q1 2026 Earnings 048 EPS Surges Past 054 Estimates Buda Juice BUDA Q1 2026 Beat Revenue NA EPS Exceeds by Significant DHI Group DHX Q1 2026 Earnings Why the Beat Matters Ingredion Incorporated INGR Stalls at 10026 Consolidation Phase 20260520 TAL TAL Stock Down 109 Support Test at 988 20260520 aTyr Pharma ATYR Q1 2026 Earnings Beat Revenue NA EPS 011 Barclays BCS Reports Strong Q1 2026 Revenue NA EPS Beats